Form 4 holding
Director
RHYTHM PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 7,000
- Estimated value
- $421,260
- Report date
- 18 Jun 2025
- Price
- $60.18
- Ownership
- Direct
Camille L. Bedrosian - Director at RHYTHM PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- RYTM on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Camille L. Bedrosian since 17 Aug 2025
Reported holdings for Camille L. Bedrosian in RHYTHM PHARMACEUTICALS, INC.
Form 4 holding
Director
RHYTHM PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Units
- Shares / value
- 4,712
- Estimated value
- $0
- Report date
- 24 Jun 2025
- Price
- $39.10
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
RHYTHM PHARMACEUTICALS, INC.
- Security class
- Stock Option (right to buy)
- Shares / value
- 7,037
- Estimated value
- Report date
- 24 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Camille L. Bedrosian in RHYTHM PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.